Ananda Pharma (STU:1FX) ROE % Adjusted to Book Value : -37.59% (As of Jul. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Ananda Pharma ROE % Adjusted to Book Value?

Ananda Pharma's ROE % for the quarter that ended in Jul. 2023 was -65.78%. Ananda Pharma's PB Ratio for the quarter that ended in Jul. 2023 was 1.75. Ananda Pharma's ROE % Adjusted to Book Value for the quarter that ended in Jul. 2023 was -37.59%.

Ananda Pharma ROE % Adjusted to Book Value Historical Data

The historical data trend for Ananda Pharma's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ananda Pharma ROE % Adjusted to Book Value Chart

Ananda Pharma Annual Data

Trend

Jan19

Jan20

Jan21

Jan22

Jan23

ROE % Adjusted to Book Value

-47.91

Ananda Pharma Semi-Annual Data
	Jul18	Jan19	Jul19	Jan20	Jul20	Jan21	Jul21	Jan22	Jul22	Jan23	Jul23
ROE % Adjusted to Book Value	Get a 7-Day Free Trial						-	-	-	-84.91	-37.59

Competitive Comparison of Ananda Pharma's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Ananda Pharma's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ananda Pharma's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ananda Pharma's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Ananda Pharma's ROE % Adjusted to Book Value falls into.

Save Embed

;

Save Embed

;

Ananda Pharma ROE % Adjusted to Book Value Calculation

Ananda Pharma's ROE % Adjusted to Book Value for the fiscal year that ended in Jan. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-172.46%	/	3.60
	=	-47.91%

Ananda Pharma's ROE % Adjusted to Book Value for the quarter that ended in Jul. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-65.78%	/	1.75
	=	-37.59%

Ananda Pharma ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Ananda Pharma's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Ananda Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ananda Pharma PLC (STU:1FX) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR

Website

https://www.anandapharma.co.uk

Ananda Pharma PLC is focused on the development of cannabinoid therapies for the treatment of a range of complex conditions. The company is developing NHS-approved and MHRA-licensed cannabinoid medicines for the treatment of drug-resistant epilepsies and specific inflammatory pain conditions (starting with CIPN & endometriosis) and HFpEF heart failure.

Ananda Pharma Headlines

No Headlines